Using fibronectin-coated culture wells, we found that DEN treatment did not induce a significant modulation of AML cell adhesion capacity and did not affect the expression of CD49e, CD49d, and CD29 integrins (data not shown). The gene discussed is ITGA5; the disease is acute myeloid leukemia.